COLUMBIA, Md., Feb. 06, 2018 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (Pink Sheets:OSIR) is pleased to announce that its Board of Directors, at a Board Meeting on February 6th, 2018, appointed Mr. Willi Miesch as a Director, upon recommendation of the Nominating Committee.  Mr. Miesch joins Osiris (the Company) as an independent Board Member and will stand […]